Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion description "[Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion evidence source_evidence_literature NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion SIO_000772 24898067 NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion wasDerivedFrom befree-2016 NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_assertion wasGeneratedBy ECO_0000203 NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.
- befree-2016 importedOn "2016-02-19" NP1188911.RAd4h8mfMmQwwYC-Kdgb4_MQG17XUzflDtq3B2ba7dm1U130_provenance.